Mar 09, 2021 / 03:55PM GMT
Balaji V. Prasad - Barclays Bank PLC, Research Division - Director
Hi. Good morning, everyone, and thank you for joining us today. So my name is Balaji Prasad.
And continuing on with the spec pharma track for the day today, we have the management team from Pacira with us today. So we have Dave Stack, Chairman and CEO; and Charlie Reinhart, CFO, with us on the call.
Dave, Charlie. Good morning. Thank you for joining us. Would you like to start with a couple of opening comments [and -- or go] more into a fireside chat?
David M. Stack - Pacira BioSciences, Inc. - Chairman & CEO
I think, Balaji, time is short. I think we usually do best here when we just jump right into Q&A, if that's okay with you.
Questions and Answers:
Balaji V. Prasad - Barclays Bank PLC, Research Division - DirectorAbsolutely. So I just want to start off with the news that had come out, the Feb sales number that came out this morning. So we have 8% sales in January, 3% in Feb. You have indicated that Q1 is probably
Trustpilot
